文献速递头颈神经MR

基于MRI的影像组学列线图鉴别眼眶孤立性纤维性肿瘤与神经鞘瘤:一项双中心研究

MRI-based radiomics nomogram for distinguishing solitary fibrous tumor from schwannoma in the orbit: a two-center study.
PubMed 文献 · Eur Radiol · 2023-08-03

该双中心回顾性研究纳入140例患者,从T2WI和增强T1WI提取106个特征构建影像组学列线图,用于鉴别眼眶孤立性纤维性肿瘤与神经鞘瘤。列线图在训练集、验证集和外部测试集的AUC分别为0.986、0.989和0.903,均高于放射科医师视觉评估的0.807、0.788和0.792,但测试集差异未达统计学显著(p=0.093)。结论认为该列线图可用于鉴别两种肿瘤,可能有助于临床肿瘤管理。

要点

  • 基于T2WI和增强T1WI的影像组学列线图鉴别眼眶SFT与神经鞘瘤,训练集AUC 0.986,验证集AUC 0.989。
  • 外部测试集列线图AUC 0.903,高于放射科医师视觉评估的0.792,但差异未达统计学显著(p=0.093)。
  • 决策曲线分析显示列线图临床实用性优于视觉评估。

核心结论

  • 基于MRI T2WI和增强T1WI的影像组学列线图可用于鉴别眼眶孤立性纤维性肿瘤与神经鞘瘤,可能有助于临床医生进行肿瘤管理。

研究设计与样本

  • 双中心回顾性研究,共纳入140例患者;机构1患者随机分为训练集(n=69)和验证集(n=35),机构2患者作为外部测试集(n=36)。

诊断标准与关键数值

  • 从T2WI和增强T1WI各提取106个特征,采用LASSO逻辑回归分别构建各序列影像组学模型并计算影像组学评分,联合模型以列线图展示;训练集列线图AUC 0.986 vs 放射科医师视觉评估AUC 0.807(p<0.001),验证集AUC 0.989 vs 0.788(p=0.009),测试集AUC 0.903 vs 0.792(p=0.093)。

临床应用与阅片要点

  • 两名放射科医师基于MRI表现联合评估肿瘤分类作为视觉评估对照;列线图在训练集和验证集AUC均高于视觉评估,测试集AUC亦高于视觉评估但差异未达统计学显著(p=0.093)。

局限性

  • 原文在测试集比较中写明未发现显著差异(p=0.093)。
  • 原文结论使用「may help tumor management by clinicians」,为可能有助于的限定表述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the value of magnetic resonance imaging (MRI) radiomics for distinguishing solitary fibrous tumor (SFT) from schwannoma in the orbit.

MATERIALS AND METHODS: A total of 140 patients from two institutions were retrospectively included. All patients from institution 1 were randomized into a training cohort (n = 69) and a validation cohort (n = 35), and patients from institution 2 were used as an external testing cohort (n = 36). One hundred and six features were extracted from T2-weighted imaging (T2WI) and contrast-enhanced T1-weighted imaging (CET1WI). A radiomics model was built for each sequence using least absolute shrinkage and selection operator logistic regression, and radiomics scores were calculated. A combined model was constructed and displayed as a radiomics nomogram. Two radiologists jointly assessed tumor category based on MRI findings. The performances of the radiomics models and visual assessment were compared via area under the curve (AUC).

RESULTS: The performances of the radiomics nomogram combining T2WI and CET1WI radiomics scores were superior to those of the pooled readers in the training (AUC 0.986 vs. 0.807, p < 0.001), validation (AUC 0.989 vs. 0.788, p = 0.009), and the testing (AUC 0.903 vs. 0.792, p = 0.093), although significant difference was not found in the testing cohort. Decision curve analysis demonstrated that the radiomics nomogram had better clinical utility than visual assessment.

CONCLUSION: MRI radiomics nomogram can be used for distinguishing between orbital SFT and schwannoma, which may help tumor management by clinicians.

CLINICAL RELEVANCE STATEMENT: It is of great importance and challenging for distinguishing solitary fibrous tumor from schwannoma in the orbit. In the present study, an MRI-based radiomics nomogram were developed and independently validated, which could help the discrimination of the two entities.

KEY POINTS: • It is challenging to differentiate solitary fibrous tumor from schwannoma in the orbit due to similar clinical and image features. • A radiomics nomogram based on T2-weighted imaging and contrast-enhanced T1-weighted imaging has advantages over radiologists. • Radiomics can provide a non-invasive diagnostic tool for differentiating between the two entities.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Ren J, Yuan Y, Qi M, et al. MRI-based radiomics nomogram for distinguishing solitary fibrous tumor from schwannoma in the orbit: a two-center study. Eur Radiol. 2023. PMID: 37532903. doi:10.1007/s00330-023-10031-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。